Viewing Study NCT06930859


Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2026-01-31 @ 10:40 PM
Study NCT ID: NCT06930859
Status: RECRUITING
Last Update Posted: 2025-12-15
First Post: 2025-04-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia
Sponsor:
Organization: